Shire Slaps Zydus With Suit Over Lialda ANDA
Shire lodged its complaint in the U.S. District Court for the District of Delaware on Wednesday, claiming Zydus has infringed U.S. Patent Number 6,773,720 by filing an abbreviated new drug application with the U.S. Food and Drug Administration for generic Lialda.
Zydus sent letters to Shire on May 27 notifying the company that it had...
Already a subscriber? Click here to login